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Acetaminophen (Paracetamol) is the most common medication
for pain and fever. There are many case reports of severe cutaneous
adverse reactions induced by acetaminophen such as anaphylaxis;
however, only a few cases of IgE-mediated hypersensitivity proved
by a skin prick test (SPT) have been reported.1e3 We described here
the ﬁrst case of acetaminophen anaphylaxis diagnosed by SPT in
Japan, and reviewed 5 case reports of acetaminophen immediate-
type reaction in Japanese patients.
A 20-year-old woman visited our department following a
recent episode of anaphylaxis. Carbocysteine, acetaminophen,
garenoxacin mesylate and tranexamic acid for tonsillitis were
prescribed. A few minutes after administration of these drugs
the patient developed urticaria and dyspnea. To identify the
cause of the anaphylaxis, a SPT was performed. The results
were positive for 100 mg/ml acetaminophen in saline (2þ)
within 15 min after application (Fig. 1a), whereas the results
for the other drugs were negative. Additional SPTs later yielded
positive results for 100 mg/ml acetaminophen (2þ) and 10 mg/
ml acetaminophen (2þ), but the reaction to 1 mg/ml acetamin-
ophen (1þ) manifested as less than 50% of the wheals produced
by histamine, and was therefore not considered clinically sig-
niﬁcant (Fig. 1b, c). Negative reactions to 100 mg/ml acetamin-
ophen by SPT were conﬁrmed in 5 healthy volunteers. Based on
these SPT results, IgE-mediated anaphylaxis due to acetamino-
phen was diagnosed. Because of the severity of her clinical
episode, intradermal and oral provocation tests (OPT) were
not performed. The patient had no history of allergy to any
food or medication. She had been working as a care taker for
the aged for 3 years and often administered acetaminophen
to the elderly. Consistently with the SPT results, she com-
plained itchiness on the thumb and ﬁngers after touching
acetaminophen.
Following its introduction in 1893, acetaminophen has been
prescribed as an antipyretic and analgesic worldwide.4 Although
the safety and efﬁcacy of acetaminophen are well established,
several case reports exist of severe cutaneous adverse effects such
as Stevens-Johnsons syndrome, toxic epidermal necrolysis, acute
generalized exanthematous pustulosis, and anaphylaxis resulting
from its use.3 In a recent report, 13 of 333 (3%) or 2 of 313 (0.6%)Peer review under responsibility of Japanese Society of Allergology.
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anaphylaxis.2,5 Anaphylactic reactions to acetaminophen are
thought to be immunologically or non-immunologically mediated.6
Non-immunologically, the drug functions as a weak inhibitor of
cyclooxygenase-1 and thus a high-dose can induce aspirin-
sensitive asthma and an anaphylactic reaction.7 On the other
hand, IgE-mediated acetaminophen-induced hypersensitivity is
extremely rare and SPT are usually negative.8 Our patient devel-
oped an urticarial rash and dyspnea a few minutes after taking
the drug, and showed positive results for a low concentration of
acetaminophen on the SPT (Fig. 1b, c). Her medical history revealed
no allergy to NSAIDs such as Loxoprofen, suggesting the diagnosis
of IgE-mediated anaphylaxis due to acetaminophen. Leung et al.
ﬁrst reported cases of acetaminophen anaphylaxis diagnosed by
OPT without co-existing aspirin intolerance,9 and was followed
by Martin et al., who reported a similar case diagnosed by SPT.1 In
a recent report, 3 of 13 patients (23.0%) in one study and 2 of 16 pa-
tients (12.5%) in another study of acetaminophen hypersensitivity
showed a positive reaction on SPT.2,3
Five cases of acetaminophen hypersensitivity without aspirin
intolerance, including the present case, have been reported dur-
ing the past 15 years in the Japanese literature (Table 1). The
gender distribution was 2 males and 3 females. The average
age was 26.8 years. The youngest patient was a 6-year-old and
the age range was wide. All patients demonstrated allergic
symptoms after ingesting acetaminophen, with anaphylaxis
occurring in 3 patients and urticaria occurring in 2 patients.
The condition was diagnosed in 4 cases with aspirin tolerance
by OPT. The positive provocation doses of acetaminophen in
these cases were 30 mg, 100 mg, 200 mg, and 300 mg. To the
best of our knowledge, the present case is the ﬁrst report of
acetaminophen-induced anaphylaxis diagnosed by SPT in Japan.
Speciﬁc IgE determination by RAST to acetaminophen was not
performed in any of the cases.
In a previous report, 100 mg/ml acetaminophen in saline
produced a positive test result, whereas 10 mg/ml produced a pos-
itive result in our patient.4 Up to now, the optimal concentration of
acetaminophen for SPT has not been established. However, based
on the above ﬁndings, a 10 mg/ml solution of acetaminophen can
be recommended for a SPT. More case reports are needed to deter-
mine the optimal concentration.vier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
Fig. 1. (a) Results of skin prick test. A positive reaction to 100 mg/ml acetaminophen (2þ). (b, c) Subsequent skin prick test. Positive reaction to 100 mg/ml acetaminophen (2þ),
10 mg/ml acetaminophen (2þ), and 1% histamine (arrow head). The reaction to 1 mg/ml acetaminophen was not considered clinically signiﬁcant (1þ).
Table 1
Review of reported cases of acetaminophen immediate-type reaction without
aspirin intolerance in Japan.
Author Age/Sex Symptoms Positive provocation
doses of
acetaminophen (mg)
Skin prick test with
acetaminophen
Tsujino
et al.
31/F Urticaria 200 Negative
Sato et al. 58/M Anaphylaxis 30 Negative
Nakamura
et al.
6/M Urticaria 100 ND
Kageyama
et al.
19/F Anaphylaxis 300 Negative
Our case 20/F Anaphylaxis ND Positive
ND, not determined.
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